VENTURE SCIENCE

Venture Science uses AI, quantitative analysis, and venture expertise to identify high-impact technology investments for accredited investors.

Venture Science provides family offices with curated investments in AI, quantum computing, and space, blending private-market growth with public-market liquidity.

Venture Science is a quantitative venture and growth investment firm using Helix, an AI-powered platform for deal sourcing, public market strategy, and fund operations.

Venture Science invests in innovative technology companies, including unicorns, for growth opportunities.

The week ending October 18, 2026, showed a divergence between large-cap tech and defensive value stocks, with the Nasdaq falling 4.48% amid AI infrastructure concerns while the Dow gained slightly as investors shifted to blue chips and energy.

Supplementing a well-managed portfolio with a technology sleeve: what wealth management does well, what it structurally cannot reach, and the risks involved.

U.S. equities rose after the S&P 500 and Nasdaq hit record highs earlier in the week, as investors weighed inflation pressures and Federal Reserve policy against expectations of 29.6% third-quarter earnings growth.

U.S. equities ended a volatile week with a Friday rally after weak September nonfarm payrolls reduced expectations of an October Federal Reserve rate hike, though the S&P 500 and Dow Jones closed lower.

Venture Science is a quantitative technology investment firm based in the San Francisco Bay Area and one of the first firms to apply decision science to venture capital.

Matt Oguz is the founder and Chief Investment Officer of Venture Science, a Silicon Valley–based investment firm specializing in AI, quantum computing, and deep-tech ventures.

How founders who have built technology companies use Strata to stay exposed to the next generation of private and public technology companies.

How registered investment advisors use Strata as a supplemental technology sleeve, reaching private and public companies alongside a core client portfolio.

Matt Oguz is the founder, Managing Partner and CIO of Venture Science, an independent quantitative venture capital firm in the San Francisco Bay Area. He leads the Venture Science Strata Fund, an evergreen hybrid fund investing in AI, quantum, longevity, space and clean energy.

Reference facts about Venture Science and the Strata Fund: firm history, fund structure, investment approach, service providers and answers to common questions.

Venture Science partners with institutional investors to provide diversified exposure to AI, quantum computing, and deep tech through disciplined, data-driven private and public market opportunities.

Venture Science uses a quantitative approach to venture capital, combining analytics with expertise in AI, quantum computing, healthcare, energy, and space technology.

Venture Science describes its analytical methods, investment philosophy, leadership, and expertise in venture capital and public markets.

Venture Science offers investment insights and support through its contact form.

The page explains Venture Science’s strategy, liquidity terms, investor eligibility, and participation for Strata Fund partners.

Pioneering quantitative investment firm in the San Francisco Bay Area, founded 2012. Manager of the Strata Fund (Bloomberg: VENSSFL US Equity).

Venture Science argues that venture capital should rely on rigorous, evidence-based decision-making rather than intuition or experience.

Investment management firm applying quantitative decision science to hybrid strategies across venture capital, growth equity, and public markets.

Strata by Venture Science: a hybrid evergreen fund investing in private and public technology companies, with annual liquidity. Bloomberg: VENSSFL US Equity.